Niedrig, D.F.; Rahmany, A.; Heib, K.; Hatz, K.-D.; Ludin, K.; Burden, A.M.; Béchir, M.; Serra, A.; Russmann, S.
Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients. J. Clin. Med. 2021, 10, 3200.
https://doi.org/10.3390/jcm10153200
AMA Style
Niedrig DF, Rahmany A, Heib K, Hatz K-D, Ludin K, Burden AM, Béchir M, Serra A, Russmann S.
Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients. Journal of Clinical Medicine. 2021; 10(15):3200.
https://doi.org/10.3390/jcm10153200
Chicago/Turabian Style
Niedrig, David F., Ali Rahmany, Kai Heib, Karl-Dietrich Hatz, Katja Ludin, Andrea M. Burden, Markus Béchir, Andreas Serra, and Stefan Russmann.
2021. "Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients" Journal of Clinical Medicine 10, no. 15: 3200.
https://doi.org/10.3390/jcm10153200
APA Style
Niedrig, D. F., Rahmany, A., Heib, K., Hatz, K.-D., Ludin, K., Burden, A. M., Béchir, M., Serra, A., & Russmann, S.
(2021). Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients. Journal of Clinical Medicine, 10(15), 3200.
https://doi.org/10.3390/jcm10153200